Putting better health within reach, every day

We develop, manufacture and market a broad range of products across the US, Canada, the Middle East and North Africa, and Europe

Global business with 32 manufacturing plants and 7 R&D centres

Global business with 32 manufacturing plants and 7 R&D centres

Europe

We manufacture injectable medicines in Europe, supplying products to the US, the MENA, and Europe. We have high-quality manufacturing plants in Germany, Italy and Portugal.

Middle East and North Africa (MENA)

The region’s principal player, we create branded generic medicines and are a leading licensing partner. In MENA, we are one of the largest pharmaceutical companies and a ‘partner of choice’.

US

We are one of the top 2 manufacturers of generic injectable medicines in the US by volume (Source: IQVIA MAT through February 2022, generic injectable volumes by eaches, excluding branded generics). We have a strong presence in the non-injectables market. We are a top-10 manufacturer of non-injectable generic medicines, including oral medications, as well as nasal sprays and inhalers. (Source: IQVIA FY 2021 non-injectable generic products only).

Canada

We market a rapidly growing and diversified portfolio of Health Canada-approved pharmaceuticals, including injectable and ophthalmic prescription medicines.

Last reviewed on 30 May 2022